Preventive cardiology: The SHAPE of the future: A synopsis from the Screening for Heart Attack Prevention and Education (SHAPE) task force report

Herz

Volumn 32, Issue 5, 2007, Pages 356-361

  Naghavi, Morteza ^a  

^a Association for Eradication of Heart Attack   (United States)

Author keywords

Acute coronary syndrome; Coronary artery disease; Heart attack; Prevention; Screening

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EDUCATION PROGRAM; FEMALE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; MALE; MEDICAL EXPERT; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; RISK ASSESSMENT; SCREENING TEST;

ATHEROSCLEROSIS; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC IMAGING; FORECASTING; HUMANS; MASS SCREENING; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; PREVENTIVE MEDICINE; SOCIETIES, MEDICAL;

EID: 34548412132     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-007-3038-4     Document Type: Article

References (10)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421 ( http://www.circ.ahajournals.org/cgi/reprint/106/25/3143).
2. Smith SC Jr, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. Circulation 2000;101:111-6.
3. De Backer G, Ambrosioni E, Borch-Johnsen K, et al., Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10 (full text available at: http://www.escardio.org/NR/ rdonlyres/A0EF5CA5-421B-45EF-A65C-19B9EC411261/0/CVD_Prevention_03_full.pdf) .
4. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
5. Akosah K, Schaper A, Cogbil C, et al. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 2003;41:1475-9.
6. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I [Review]. Circulation 2003;108:1664-72.
7. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II [Review]. Circulation 2003;108:1772-8.
8. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999;282:2012-8.
9. Naghavi M, Falk E, Hecht H, et al. From vulnerable plaque to vulnerable patient: part III. Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force. Am J Cardiol 2006;98:1-15H.
10. Kalia NK, Miller LG, Nasir K, et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis 2006;185:394-9.